These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 18676056
1. Induction therapy of loco-regional non-small-cell lung cancer with reliable response and low toxicity (low dose radiotherapy sensitizes tumor to subsequent chemotherapy?). Takita H, Shin KH, Soh AY, Yi WS, Wilding G. Lung Cancer; 2009 Mar; 63(3):387-92. PubMed ID: 18676056 [Abstract] [Full Text] [Related]
2. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. van Meerbeeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F, Tjan-Heijnen VC, Biesma B, Debruyne C, van Zandwijk N, Splinter TA, Giaccone G, European Organisation for Research and Treatment of Cancer-Lung Cancer Group. J Natl Cancer Inst; 2007 Mar 21; 99(6):442-50. PubMed ID: 17374834 [Abstract] [Full Text] [Related]
3. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response. Pourel N, Santelmo N, Naafa N, Serre A, Hilgers W, Mineur L, Molinari N, Reboul F. Eur J Cardiothorac Surg; 2008 May 21; 33(5):829-36. PubMed ID: 18367406 [Abstract] [Full Text] [Related]
4. Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapy. Graham PH, Clark C, Abell F, Browne L, Capp A, Clingan P, De Sousa P, Fox C, Links M. Australas Radiol; 2006 Aug 21; 50(4):342-8. PubMed ID: 16884421 [Abstract] [Full Text] [Related]
5. Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet. Fischer S, Darling G, Pierre AF, Sun A, Leighl N, Waddell TK, Keshavjee S, de Perrot M. Eur J Cardiothorac Surg; 2008 Jun 21; 33(6):1129-34. PubMed ID: 18407511 [Abstract] [Full Text] [Related]
6. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer]. Mito A, Yamasaki M, Matsuura K, Kajihara T, Nitta T, Awaya H, Arita K, Kashiwado K, Ohashi N. Gan To Kagaku Ryoho; 2009 Oct 21; 36(10):1653-6. PubMed ID: 19838022 [Abstract] [Full Text] [Related]
7. Three-times-daily radiotherapy with induction chemotherapy in locally advanced non-small cell lung cancer. Feasibility and toxicity study. Catalano G, Jereczek-Fossa BA, De Pas T, Leon ME, Cattani F, Spaggiari L, Veronesi G, de Braud F, Orecchia R. Strahlenther Onkol; 2005 Jun 21; 181(6):363-71. PubMed ID: 15925978 [Abstract] [Full Text] [Related]
8. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM. Cancer; 2009 Sep 15; 115(18):4156-66. PubMed ID: 19551884 [Abstract] [Full Text] [Related]
9. Induction chemotherapy followed by concurrent chemoradiation for patients with non-operable stage III non-small-cell lung cancer. Iranzo V, Bremnes RM, Almendros P, Gavilá J, Blasco A, Sirera R, Camps C. Lung Cancer; 2009 Jan 15; 63(1):63-7. PubMed ID: 18550204 [Abstract] [Full Text] [Related]
10. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. Hata M, Tokuuye K, Kagei K, Sugahara S, Nakayama H, Fukumitsu N, Hashimoto T, Mizumoto M, Ohara K, Akine Y. Int J Radiat Oncol Biol Phys; 2007 Jul 01; 68(3):786-93. PubMed ID: 17379439 [Abstract] [Full Text] [Related]
11. Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer? Park BB, Park JO, Kim H, Ahn YC, Choi YS, Kim K, Kim J, Shim YM, Ahn JS, Park K. Lung Cancer; 2006 Sep 01; 53(3):323-30. PubMed ID: 16844258 [Abstract] [Full Text] [Related]
13. Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer. Tell R, Sederholm C, Klintenberg C, Franksson L, Brandén E, Hillerdal G, Lönn U, Lindén CJ, Ewers SB, Lamberg K, Mrazek E, Lödén B, Sjögren A, Linné T, Friesland S, Sirzén F. Anticancer Res; 2008 Sep 01; 28(5B):2851-7. PubMed ID: 19031924 [Abstract] [Full Text] [Related]
14. Pulmonary resection after high-dose and low-dose chest irradiation. Cerfolio RJ, Bryant AS, Spencer SA, Bartolucci AA. Ann Thorac Surg; 2005 Oct 01; 80(4):1224-30; discussion 1230. PubMed ID: 16181844 [Abstract] [Full Text] [Related]
15. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study. Cho KH, Ahn SJ, Pyo HR, Kim KS, Kim YC, Moon SH, Han JY, Kim HT, Koom WS, Lee JS. Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1397-404. PubMed ID: 19117690 [Abstract] [Full Text] [Related]
19. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, Mohan R, Cox JD, Komaki R. Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1399-407. PubMed ID: 16997503 [Abstract] [Full Text] [Related]